Piramal Pharma Limited (PPLPHARMA) — Free Cash Flow Generation Index
Piramal Pharma Limited (PPLPHARMA) has a Free Cash Flow Generation Index of 0.51x as of September 2025. Free cash flow of Rs4.57 Billion represents 1% of operating cash flow (Rs8.90 Billion). See how liquid is Piramal Pharma Limited's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Piramal Pharma Limited Free Cash Flow Generation Index (2021–2026)
Historical FCF Generation Index trend for Piramal Pharma Limited across 6 annual periods. Explore Piramal Pharma Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Piramal Pharma Limited (2021–2026)
Year-by-year Free Cash Flow Generation Index for Piramal Pharma Limited. For the full company profile including market capitalisation, see Piramal Pharma Limited market capitalisation.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.36x | Rs5.10 Billion | Rs14.00 Billion | Rs8.90 Billion | ▲ +42.5% |
| 2025 | 0.26x | Rs2.28 Billion | Rs8.92 Billion | Rs6.64 Billion | ▼ -12.3% |
| 2024 | 0.29x | Rs2.92 Billion | Rs10.05 Billion | Rs7.12 Billion | ▲ +129.3% |
| 2023 | -0.99x | Rs-4.81 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -563.7% |
| 2022 | 0.21x | Rs546.90 Million | Rs2.55 Billion | Rs2.01 Billion | ▲ +131.8% |
| 2021 | -0.67x | Rs-233.90 Million | Rs347.20 Million | Rs581.10 Million | — |